NO891045L - Fremgangsmaate for fremstilling av terapeutisk aktive kinolin-2,5-dion-derivater. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive kinolin-2,5-dion-derivater.Info
- Publication number
- NO891045L NO891045L NO89891045A NO891045A NO891045L NO 891045 L NO891045 L NO 891045L NO 89891045 A NO89891045 A NO 89891045A NO 891045 A NO891045 A NO 891045A NO 891045 L NO891045 L NO 891045L
- Authority
- NO
- Norway
- Prior art keywords
- quinolin
- procedure
- preparation
- therapeutic active
- dion derivatives
- Prior art date
Links
- 229920004518 DION® Polymers 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
- C07D221/12—Phenanthridines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3808136A DE3808136A1 (de) | 1988-03-11 | 1988-03-11 | Arzneimittel, enthaltend chinolin-2,5-dione, neue chinolin-2,5-dione und verfahren zu ihrer herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO891045D0 NO891045D0 (no) | 1989-03-10 |
| NO891045L true NO891045L (no) | 1989-09-12 |
Family
ID=6349485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO89891045A NO891045L (no) | 1988-03-11 | 1989-03-10 | Fremgangsmaate for fremstilling av terapeutisk aktive kinolin-2,5-dion-derivater. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5068334A (no) |
| EP (1) | EP0338228A3 (no) |
| JP (1) | JPH01299273A (no) |
| KR (1) | KR890014488A (no) |
| AU (1) | AU616487B2 (no) |
| DD (1) | DD283610A5 (no) |
| DE (1) | DE3808136A1 (no) |
| DK (1) | DK117389A (no) |
| FI (1) | FI891154A (no) |
| HU (2) | HU205080B (no) |
| IL (1) | IL89569A (no) |
| NO (1) | NO891045L (no) |
| NZ (1) | NZ228286A (no) |
| PH (1) | PH27106A (no) |
| PT (1) | PT89981B (no) |
| SU (1) | SU1660581A3 (no) |
| ZA (1) | ZA891798B (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109232416B (zh) * | 2018-10-24 | 2021-09-24 | 福州大学 | 一种合成4-三氟甲基-2-吡喃酮/吡啶酮化合物的方法 |
| CN111978281B (zh) * | 2020-09-02 | 2023-03-28 | 河南师范大学 | 一种制备环己酮/色烯并吡喃酮类化合物的方法及其化合物应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS48103590A (no) * | 1972-04-13 | 1973-12-25 | ||
| JPS51104787A (ja) * | 1975-03-12 | 1976-09-16 | Kyoshi Okano | Nenseiryutaifuiidosochi |
| DE2854498A1 (de) * | 1978-12-16 | 1980-06-26 | Thomae Gmbh Dr K | Neue 7,8-dihydro-2,5(1h,6h)chinolindione, ihre herstellung und ihre verwendung als arzneimittel |
| JPS57146759A (en) * | 1981-03-06 | 1982-09-10 | Otsuka Pharmaceut Co Ltd | Preparation of 5-hydroxycarbostyril |
-
1988
- 1988-03-11 DE DE3808136A patent/DE3808136A1/de not_active Withdrawn
-
1989
- 1989-03-06 DD DD89326308A patent/DD283610A5/de not_active IP Right Cessation
- 1989-03-07 EP EP19890103966 patent/EP0338228A3/de not_active Ceased
- 1989-03-09 NZ NZ228286A patent/NZ228286A/en unknown
- 1989-03-09 ZA ZA891798A patent/ZA891798B/xx unknown
- 1989-03-10 NO NO89891045A patent/NO891045L/no unknown
- 1989-03-10 FI FI891154A patent/FI891154A/fi not_active Application Discontinuation
- 1989-03-10 HU HU902441A patent/HU205080B/hu not_active IP Right Cessation
- 1989-03-10 KR KR1019890002943A patent/KR890014488A/ko not_active Application Discontinuation
- 1989-03-10 JP JP1059464A patent/JPH01299273A/ja active Pending
- 1989-03-10 SU SU894613665A patent/SU1660581A3/ru active
- 1989-03-10 HU HU891192A patent/HU204256B/hu not_active IP Right Cessation
- 1989-03-10 IL IL8956989A patent/IL89569A/en unknown
- 1989-03-10 PT PT89981A patent/PT89981B/pt not_active IP Right Cessation
- 1989-03-10 AU AU31188/89A patent/AU616487B2/en not_active Ceased
- 1989-03-10 DK DK117389A patent/DK117389A/da not_active Application Discontinuation
- 1989-08-13 PH PH38319A patent/PH27106A/en unknown
- 1989-09-27 US US07/413,369 patent/US5068334A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO891045D0 (no) | 1989-03-10 |
| PH27106A (en) | 1993-03-16 |
| PT89981A (pt) | 1989-11-10 |
| US5068334A (en) | 1991-11-26 |
| JPH01299273A (ja) | 1989-12-04 |
| HU205080B (en) | 1992-03-30 |
| SU1660581A3 (ru) | 1991-06-30 |
| AU616487B2 (en) | 1991-10-31 |
| HU204256B (en) | 1991-12-30 |
| DK117389D0 (da) | 1989-03-10 |
| HUT53084A (en) | 1990-09-28 |
| PT89981B (pt) | 1994-05-31 |
| IL89569A (en) | 1994-02-27 |
| HU902441D0 (en) | 1990-08-28 |
| EP0338228A2 (de) | 1989-10-25 |
| FI891154A0 (fi) | 1989-03-10 |
| DK117389A (da) | 1989-09-12 |
| EP0338228A3 (de) | 1991-07-10 |
| FI891154A (fi) | 1989-09-12 |
| ZA891798B (en) | 1990-11-28 |
| IL89569A0 (en) | 1989-09-10 |
| KR890014488A (ko) | 1989-10-24 |
| DE3808136A1 (de) | 1989-09-21 |
| DD283610A5 (de) | 1990-10-17 |
| AU3118889A (en) | 1989-09-14 |
| NZ228286A (en) | 1990-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO894630D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater. | |
| NO904694D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
| NO901684D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater. | |
| NO883974D0 (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
| NO871266L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO870075L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater. | |
| NO870526L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. | |
| NO903088L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater. | |
| NO880182D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater. | |
| NO874032L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
| NO875488D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
| NO893909D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater. | |
| NO891723D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. | |
| NO890607D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater. | |
| NO900972L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
| NO871907D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater. | |
| NO900942D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater. | |
| NO891045L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolin-2,5-dion-derivater. | |
| NO890724D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater. | |
| NO890519D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater. | |
| NO904470D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater. | |
| NO891677L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater. | |
| NO890506L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kloranilin-derivater. | |
| NO860065L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminofenolderivater. |